Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

KFDA Clearance for StoneChecker Software

20 Jan 2020 07:00

RNS Number : 2389A
IQ-AI Limited
20 January 2020
 

IQ-AI Ltd

("IQ-AI" or the "Company")

 

IQ-AI Announce Korean FDA Clearance to Market for StoneChecker Software, and GMP certification for Imaging Biometrics, and the appointment of Dr Balaji Ganeshan as consultant

 

IQ-AI has received notification that the Korean FDA (KFDA) has cleared StoneChecker Software for marketing in the Republic of Korea, a key market for high-tech medical imaging hardware and software. In addition, Imaging Biometrics (IB) has received GMP certification.

 

Trevor Brown, Chief Executive of IQ-AI commented, "We are delighted that StoneChecker Software has received KFDA approval for marketing in the Republic of Korea, our Korean distributor's marketing plans can now be fully implemented. It also gives me great pleasure to welcome back Dr Balaji Ganeshan to the team. Dr Ganeshan, an exceptionally innovative medical imaging entrepreneur and scientist, has invaluable expertise and ideas in a number of key technologies relevant to the Company. He will be working as a consultant for IB."

 

Dr Ganeshan, who was previously a director of StoneChecker Software, holds the position of Senior Research Associate at the Institute of Nuclear Medicine at University College London and is a prolific academic scientist in the area of medical image analysis. 

 

Dr. Balaji Ganeshan commented, "I very much look forward to working alongside Trevor Brown again, and also the team at IB, on all the technologies that IQ-AI have access to."

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

 

For further information, please contact:

IQ-AI Limited

Trevor Brown/Michael Schmainda

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

About IQ-AI Ltd 

IQ-AI, Ltd, the parent company of StoneChecker® and Imaging Biometrics®, is focused on advanced and state of the art medical software and services. Imaging Biometrics develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. Please visit www.imagingbiometrics.com for further information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRSFFFAUESSEEF
Date   Source Headline
22nd Jan 20077:02 amRNSTrading Statement
19th Jan 20072:45 pmRNSHolding(s) in Company
15th Jan 20071:41 pmRNSHolding(s) in Company
13th Dec 200612:19 pmRNSTotal Voting Rights
29th Nov 20069:01 amRNSShareholder & Board Change
18th Oct 20062:16 pmRNSHolding(s) in Company
16th Oct 200611:49 amRNSHolding(s) in Company
26th Sep 200610:31 amRNSBlocklisting Interim Review
21st Sep 200610:12 amRNSHolding(s) in Company
18th Sep 20067:01 amRNSAcquisition
10th Aug 200610:19 amRNSHolding(s) in Company
8th Aug 20067:01 amRNSTransaction in Own Shares
28th Jul 20067:01 amRNSInterim Results
18th Jul 20067:00 amRNSNotice of Interim Results
27th Jun 20064:52 pmRNSChange of Auditors
3rd May 20065:09 pmRNSDirectorate Change
28th Apr 20067:01 amRNSHolding(s) in Company
13th Apr 200610:15 amRNSAGM Statement
6th Apr 200610:26 amRNSDirector/PDMR Shareholding
24th Mar 20064:17 pmRNSAdditional Listing - Replace
23rd Mar 20063:28 pmRNSAdditional Listing
16th Mar 20063:18 pmRNSDirector/PDMR Shareholding
14th Mar 20063:43 pmRNSAnnual Information Update
14th Mar 200612:26 pmRNSDirector/PDMR Shareholding
10th Mar 20067:01 amRNSDirectorate Change
10th Mar 20067:01 amRNSFinal Results
27th Feb 200611:00 amRNSNotice of Results
10th Jan 20067:00 amRNSTrading Statement
9th Dec 20054:07 pmRNSTransaction in Own Shares
14th Nov 20057:01 amRNSChange of Adviser
21st Oct 200512:28 pmRNSHolding(s) in Company
18th Oct 20058:00 amRNSTransaction in Own Shares
17th Oct 20057:00 amRNSTransaction in Own Shares
10th Oct 20054:39 pmRNSTransaction in Own Shares
30th Sep 200511:58 amRNSAcquisition of GBS-replacemt
30th Sep 20057:01 amRNSAcquisition of GBS
29th Sep 20054:00 pmRNSDirectorate Change
24th Aug 200512:18 pmRNSAdditional Listing
12th Aug 200512:58 pmRNSDirector/PDMR Shareholding
11th Aug 200511:58 amRNSAdditional Listing
11th Aug 200511:37 amRNSDirector Shareholding
9th Aug 200511:00 amRNSDirector Shareholding
29th Jul 20057:00 amRNSInterim Results
7th Jul 20057:00 amRNSNotice of Results
5th Jul 200511:00 amRNSChange of Adviser
12th May 20058:27 amRNSTransaction in Own Shares
20th Apr 20057:46 amRNSDirector Shareholding
18th Apr 20052:54 pmRNSAcquisition Completion
18th Apr 20059:32 amRNSDirector Shareholding
4th Apr 200512:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.